您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > OAC1
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
OAC1
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
OAC1图片
CAS NO:300586-90-7
包装与价格:
包装价格(元)
10mM (in 1mL DMSO)电议
10mg电议
50mg电议

产品介绍
OAC1 是一种有效的 Oct4 激活剂。 OAC1 激活 Oct4 和 Nanog 启动子并增强诱导多能干细胞 (iPSC) 的形成。 OAC1 通过上调 HOXB4 表达激活 OCT4。 OAC1 增加 Oct4-Nanog-Sox2 三联体和 Tet1 的转录。 OAC1 通过提高效率和缩短重编程时间来促进细胞的重编程。
Cas No.300586-90-7
别名N-1H-吡咯并[2,3-C]吡啶-5-基苯甲酰胺
化学名N-(1H-pyrrolo[2,3-c]pyridin-5-yl)benzamide
Canonical SMILESC1=CC=C(C=C1)C(=O)NC2=NC=C3C(=C2)C=CN3
分子式C14H11N3O
分子量237.26
溶解度≥ 9.9mg/mL in DMSO
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

OAC1 is an activator of Oct4 [1].

Octamer-binding transcription factor 4 (Oct4) is a regulator of embryonic stem cell (ESC) pluripotency and the reprogramming process. High expression of Oct4 results in differentiation of ESCs along the mesodermal and primitive endodermal lineages. However, low expression of Oct4 leads to differentiation of ESCs into trophectodermal cells [1].

OAC1 is an Oct4 activator. In luciferase reporter assays, OAC1 activated both human Oct4 and Nanog promoter-driven luciferase reporter genes. In mouse embryonic fibroblasts (MEFs) with the 4F reprogramming quartet Oct4, Klf4, Sox2, and c-Myc, OAC1 enhanced reprogramming efficiency and increased the number of colonies with ESC-like morphology by twofold or more. Also, OAC1 increased induced pluripotent stem cells (iPSC)-like colonies. OAC1 had no effects on the Wnt signaling and p53-p21 expression. In MEFs, OAC1 activated the expression of endogenous Oct4 and Nanog. Also, OAC1 increased the expression of Sox2 and Tet1 [1].

Reference:
[1].  Li W, Tian E, Chen ZX, et al. Identification of Oct4-activating compounds that enhance reprogramming efficiency. Proc Natl Acad Sci U S A, 2012, 109(51): 20853-20858.